Ronen Durst

ORCID: 0000-0003-3559-1050
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Cardiac Valve Diseases and Treatments
  • Cardiac Imaging and Diagnostics
  • Infective Endocarditis Diagnosis and Management
  • Aortic Disease and Treatment Approaches
  • Congenital Heart Disease Studies
  • Congenital heart defects research
  • Cancer, Lipids, and Metabolism
  • Cardiac Structural Anomalies and Repair
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Function and Risk Factors
  • Cholesterol and Lipid Metabolism
  • Atherosclerosis and Cardiovascular Diseases
  • Cardiac tumors and thrombi
  • COVID-19 Clinical Research Studies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pancreatic function and diabetes
  • Viral Infections and Immunology Research
  • Genetic Associations and Epidemiology
  • Parathyroid Disorders and Treatments
  • Cardiovascular Effects of Exercise
  • Diet and metabolism studies
  • Cardiac electrophysiology and arrhythmias
  • Connective tissue disorders research
  • Genetic factors in colorectal cancer

Hadassah Medical Center
2015-2024

Hebrew University of Jerusalem
2001-2024

University Medical Center
2010-2024

Magee-Womens Hospital
2021

European Atherosclerosis Society
2021

Hôpital Européen Georges-Pompidou
2021

University of Basel
2016

University of Cape Town
2016

National Health Laboratory Service
2016

Heidelberg University
2016

Antonio J. Vallejo‐Vaz C. Stevens Alexander R.M. Lyons Kanika Dharmayat Tomáš Freiberger and 95 more G. Kees Hovingh Pedro Mata Frederick J. Raal Raúl D. Santos Handrean Soran Gerald F. Watts Marianne Abifadel Carlos A. Aguilar-Salinas Khalid F. AlHabib Mutaz Al-Khnifsawi Wael Almahmeed Fahad Alnouri Rodrigo Alonso Khalid Al‐Rasadi Ahmad Al‐Sarraf Nasreen Al-Sayed Francisco Araújo Tester F. Ashavaid Maciej Banach Sophie Béliard Marianne Benn Christoph J. Binder Martin P. Bogsrud Mafalda Bourbon Krzysztof Chlebus Pablo Corral Kairat Davletov Olivier Descamps Ronen Durst М. В. Ежов Dan Gaiţă Jacques Genest Urh Grošelj Mariko Harada‐Shiba Kirsten B. Holven Meral Kayıkçıoğlu Weerapan Khovidhunkit Katarina Lalić Gustavs Latkovskis Ulrich Laufs Evangelos Liberopoulos Marcos M. Lima-Martínez Jie Lin Vincent Maher Adéle Marais Winfried März Erkin М Мirrakhimov André R. Miserez Olena Mitchenko Hapizah Nawawi Børge G. Nordestgaard Andrie G. Panayiotou György Paragh Žaneta Petrulionienė Belma Pojskić Arman Postadzhiyan Katarı́na Rašlová Ashraf Reda Željko Reiner Fouzia Sadiq Wilson E. Sadoh Heribert Schunkert Aleksandr B. Shek Mario Stoll Erik S.G. Stroes Ta‐Chen Su Subramaniam Tavintharan Andrey V. Susekov Myra Tilney Brian Tomlinson Thanh Huong Truong Alexandros D. Tselepis Anne Tybjærg‐Hansen Alejandra Cárdenas Margus Viigimaa Luya Wang Shizuya Yamashita John J.P. Kastelein Éric Bruckert Branislav Vohnout Laura Schreier Jing Pang Christoph Ebenbichler Hans Dieplinger Reinhold Innerhofer Yvonne Winhofer-Stöckl Susanne Greber‐Platzer Konstantin A. Krychtiuk Walter S. Speidl Hermann Toplak Kurt Widhalm Thomas M. Stulnig Kurt Huber Florian Höllerl Gersina Rega‐Kaun

10.1016/s0140-6736(21)01122-3 article EN The Lancet 2021-09-07

10.1016/j.atherosclerosis.2018.08.051 article EN Atherosclerosis 2018-09-28

Abstract BACKGROUND Familial hypercholesterolemia (FH) is an autosomal-dominant disorder caused by mutations in 1 of 3 genes. In the 60% patients who are mutation negative, we have recently shown that clinical phenotype can be associated with accumulation common small-effect LDL cholesterol (LDL-C)-raising alleles use a 12–single nucleotide polymorphism (12-SNP) score. The aims study were to improve selection SNPs and replicate results additional samples. METHODS We used ROC curves determine...

10.1373/clinchem.2014.231365 article EN Clinical Chemistry 2014-11-21
Tycho R. Tromp Merel L. Hartgers G. Kees Hovingh Antonio J. Vallejo‐Vaz Kausik K. Ray and 95 more Handrean Soran Tomáš Freiberger Stefano Bertolini Mariko Harada‐Shiba Dirk Blom Frederick J. Raal Marina Cuchel Tycho R. Tromp Merel L. Hartgers G. Kees Hovingh Antonio J. Vallejo‐Vaz Kausik K. Ray Handrean Soran Tomáš Freiberger Stefano Bertolini Mariko Harada‐Shiba Jing Pang Gerald F. Watts Susanne Greber‐Platzer Martin Mäser Thomas M. Stulnig Christoph Ebenbichler Khalid Bin Thani David Cassiman Olivier Descamps Daisy Rymen Peter Witters Raúl D. Santos Liam R. Brunham Gordon A. Francis Jacques Genest Robert A. Hegele Brooke A. Kennedy Isabelle L. Ruel Mark Sherman Long Jiang Luya Wang Željko Reiner V. Bláha R Češka Jana Dvořáková Lubomir Dlouhy Pavel Hořák Vladimír Soška Lukáš Tichý Robin Urbánek H Vaverková Michal Vráblík Stanislav Zemek Lukáš Zlatohlávek Sameh Emil Tarek Naguib Ashraf Reda Sophie Béliard Éric Bruckert Antonio Gallo Moses Elisaf Genovefa Kolovou Hofit Cohen Ronen Durst Eldad J. Dann Avishay Elis Osama Hussein Eran Leitersdorf Daniel Schurr Nitika Setia Ishwar C. Verma Mohammed Alareedh Mutaz Al-Khnifsawi Ali Fawzi Abdalsahib Sabah H. Rhadi Foaad Shaghee Marcello Arca Maurizio Averna Andrea Bartuli Marco Bucci Paola Sabrina Buonuomo Paolo Calabrò S. Calandra Manuela Casula Alberico L. Catapano Angelo B. Cefalú Arrigo F.G. Cicero Sergio D’Addato Laura D’Erasmo Alessia Di Costanzo Tommaso Fasano Marta Gazzotti Antonina Giammanco Gabriella Iannuzzo Anastasia Ibba Emanuele Alberto Negri Andrea Pasta Chiara Pavanello Livia Pisciotta

10.1016/s0140-6736(21)02001-8 article EN The Lancet 2022-01-28

Recommendations for moderate alcohol consumption remain controversial, particularly in type 2 diabetes mellitus (T2DM). Long-term randomized, controlled trials (RCTs) are lacking.To assess cardiometabolic effects of initiating intake persons with T2DM and whether the wine matters.2-year RCT (CASCADE [CArdiovaSCulAr Diabetes & Ethanol] trial). (ClinicalTrials.gov: NCT00784433).Ben-Gurion University Negev-Soroka Medical Center Nuclear Research Negev, Israel.Alcohol-abstaining adults...

10.7326/m14-1650 article EN Annals of Internal Medicine 2015-10-13

Familial hypercholesterolaemia (FH) is an autosomal dominant disease of lipid metabolism, which leads to early coronary heart disease. Mutations in LDLR, APOB and PCSK9 can be detected 80% definite FH (DFH) patients. This study aimed identify novel FH-causing genetic variants patients with no detectable mutation.Exomes 125 unrelated DFH were sequenced, as part the UK10K project. First, analysis known genes identified 23 LDLR two mutations, explained causes excluded from further analysis....

10.1136/jmedgenet-2014-102405 article EN cc-by Journal of Medical Genetics 2014-07-01

The potential for global collaborations to better inform public health policy regarding major non-communicable diseases has been successfully demonstrated by several large-scale international consortia. However, the true impact of familial hypercholesterolaemia (FH), a common genetic disorder associated with premature cardiovascular disease, is yet be reliably ascertained using similar approaches. European Atherosclerosis Society FH Studies Collaboration (EAS FHSC) new initiative...

10.1016/j.atherosclerosissup.2016.10.001 article EN cc-by-nc-nd Atherosclerosis Supplements 2016-12-01

Mitral valve prolapse (MVP) affects 1 in 40 people and is the most common indication for mitral surgery. MVP can cause arrhythmias, heart failure, sudden cardiac death, to date, causes of this disease are poorly understood. We now demonstrate that defects primary cilia genes their regulated pathways familial sporadic nonsyndromic cases. Our expression studies genetic ablation experiments confirmed a role regulating ECM deposition during development. Loss development resulted progressive...

10.1126/scitranslmed.aax0290 article EN Science Translational Medicine 2019-05-22

BACKGROUND: Homozygous familial hypercholesterolemia is a genetic disease characterized by extremely high levels of low-density lipoprotein cholesterol (LDL-C) and risk premature cardiovascular events. The proof-of-concept study ORION-2 (A Study Inclisiran in Participants With Familial Hypercholesterolemia) showed that inclisiran, small interfering RNA prevents production the hepatic PCSK9 protein (proprotein convertase subtilisin/kexin type 9), could lead to durable reductions LDL-C when...

10.1161/circulationaha.122.063460 article EN cc-by Circulation 2023-10-18
Kanika Dharmayat Antonio J. Vallejo‐Vaz C. Stevens Julia Brandts Alexander R.M. Lyons and 95 more Urh Grošelj Marianne Abifadel Carlos A. Aguilar‐Salinas Khalid F. AlHabib Mutaz Al-Khnifsawi Wael Almahmeed Fahad Alnouri Rodrigo Alonso Khalid Al‐Rasadi Tester F. Ashavaid Maciej Banach Sophie Béliard Christoph J. Binder Mafalda Bourbon Krzysztof Chlebus Pablo Corral Diogo Cruz Olivier Descamps Euridiki Drogari Ronen Durst М. В. Ежов Jacques Genest Mariko Harada‐Shiba Kirsten B. Holven Steve E. Humphries Weerapan Khovidhunkit Katarina Lalić Ulrich Laufs Evangelos Liberopoulos Jeanine E. Roeters van Lennep Marcos M. Lima-Martínez Jie Lin Vincent Maher Winfried März André R. Miserez Olena Mitchenko Hapizah Nawawi Andrie G. Panayiotou György Paragh Arman Postadzhiyan Ashraf Reda Željko Reiner Ximena Reyes Fouzia Sadiq Amirhossein Sahebkar Heribert Schunkert Aleksandr B. Shek E.S.G. Stroes Ta‐Chen Su Subramaniam Tavintharan Andrey V. Susekov Alejandra Cárdenas Thanh Huong Truong Alexandros D. Tselepis Branislav Vohnout Luya Wang Shizuya Yamashita Ahmad Al‐Sarraf Nasreen Al-Sayed Kairat Davletov Bambang Dwiputra Dan Gaiţă Meral Kayıkçıoğlu Gustavs Latkovskis Adéle Marais Anne Thushara Matthias Erkin М Мirrakhimov Børge G. Nordestgaard Žaneta Petrulionienė Belma Pojskić Wilson E. Sadoh Myra Tilney Brian Tomlinson Anne Tybjærg‐Hansen Margus Viigimaa Alberico L. Catapano Tomáš Freiberger G. Kees Hovingh Pedro Mata Handrean Soran Frederick J. Raal Gerald F. Watts Laura Schreier Virginia Bañares Susanne Greber‐Platzer Margot Baumgartner-Kaut Charlotte de Gier Hans Dieplinger Florian Höllerl Reinhold Innerhofer Daniela Karall Julia Lischka Bernhard Ludvik Martin Mäser Sabine Scholl‐Bürgi

<h2>Summary</h2><h3>Background</h3> Approximately 450 000 children are born with familial hypercholesterolaemia worldwide every year, yet only 2·1% of adults were diagnosed before age 18 years via current diagnostic approaches, which derived from observations in adults. We aimed to characterise and adolescents heterozygous (HeFH) understand approaches the identification management inform future public health strategies. <h3>Methods</h3> For this cross-sectional study, we assessed younger...

10.1016/s0140-6736(23)01842-1 article EN cc-by-nc-nd The Lancet 2023-12-12

Abstract Background and Aims Lerodalcibep, a novel small recombinant fusion protein of proprotein convertase subtilisin/kexin type 9 gene–binding domain (adnectin) human serum albumin, demonstrated highly effective low-density lipoprotein cholesterol (LDL-C) reduction with monthly 300 mg in 1.2 mL subcutaneous dosing Phase 2. In this global 3 trial, the safety efficacy lerodalcibep were evaluated heterozygous familial hypercholesterolaemia patients requiring additional LDL-C lowering....

10.1093/eurheartj/ehad596 article EN cc-by European Heart Journal 2023-08-28
Janneke W. C. M. Mulder Tycho R. Tromp Mutaz Al-Khnifsawi Dirk Blom Krysztof Chlebus and 95 more Marina Cuchel Laura D’Erasmo Antonio Gallo G. Kees Hovingh Ngoc‐Thanh Kim Long Jiang Frederick J. Raal Willemijn A.M. Schonck Handrean Soran Thanh‐Huong Truong Eric Boersma Jeanine E. Roeters van Lennep Mohammed Alareedh Rano Alieva Massimiliano Allevi Bülent B. Altunkeser Khalid Al-Waili Ali Fawzi Abdalsahib Marcello Arca Luigi Atzori Maurizio Averna Mahmoud H. Ayesh Sami T. Azar Giuseppe Banderali Francesco Baratta Andrea Bartuli Sophie Béliard Vanessa Bianconi Simone Bini Khalid Bin Thani Fadi Bitar V. Bláha Katia Bonomo Mafalda Bourbon Adriana Branchi Julie A. Brothers Éric Bruckert Liam R. Brunham Patrizia Bruzzi Marco Bucci Paola Sabrina Buonuomo Paolo Calabrò S. Calandra Francesca Carubbi David Cassiman Manuela Casula Alberico L. Catapano Franco Cavalot Angelo B. Cefalú Arturo Cesaro R Češka Min‐Ji Charng Francesco Cipollone Hofit Cohen Sergio D’Addato Beatrice Dal Pino Eldad J. Dann Joep C. Defesche Maria Del Ben Si̇nan Demi̇rci̇oğlu Olivier Descamps Alessia Di Costanzo Maria Donata Di Taranto Doan‐Loi Do Ronen Durst Jana Dvořáková Christoph Ebenbichler Avishay Elis Sameh Emil М. В. Ежов Akl C. Fahed Tommaso Fasano Claudio Ferri Federica Fogacci Elena Formisano Giuliana Fortunato Gordon A. Francis Tomáš Freiberger Federica Galimberti Isabel Gaspar Jacques Genest Marco Gentile Antonina Giammanco Cumali Gökçe Susanne Greber‐Platzer Liliana Grigore Urh Grošelj Mariko Harada‐Shiba Merel L. Hartgers Robert A. Hegele Pavel Hořák Mika Hori Lisa C. Hudgins Osama Hussein Gabriella Iannuzzo

Homozygous familial hypercholesterolemia (HoFH) is a rare genetic condition characterized by extremely increased low-density lipoprotein (LDL) cholesterol levels and premature atherosclerotic cardiovascular disease (ASCVD). Heterozygous (HeFH) more common than HoFH, women with HeFH are diagnosed later undertreated compared to men; it unknown whether these sex differences also apply HoFH.

10.1001/jamacardio.2023.5597 article EN JAMA Cardiology 2024-02-14

A bstract : Background: Genetic variation in the alcohol dehydrogenase (ADH) enzyme is associated with an aversion to and a lower risk of alcoholism among Asians. There growing evidence functional role ADH2*2 allele alcohol‐drinking patterns Jews, who have traditionally exhibited low rates alcohol‐related problems. The mechanism by which this allelic effect mediated not yet clearly understood. This study examined on alcohol‐elimination (AER) under experimental conditions. Methods: Young...

10.1097/01.alc.0000108667.79219.4d article EN Alcoholism Clinical and Experimental Research 2004-01-01

Cannabidiol (CBD) is a major, nonpsychoactive Cannabis constituent with anti-inflammatory activity mediated by enhancing adenosine signaling. Inasmuch as receptors are promising pharmaceutical targets for ischemic heart diseases, we tested the effect of CBD on rat hearts. For in vivo studies, left anterior descending coronary artery was transiently ligated 30 min, and rats were treated 7 days (5 mg/kg ip) or vehicle. Cardiac function studied echocardiography. Infarcts examined...

10.1152/ajpheart.00098.2007 article EN AJP Heart and Circulatory Physiology 2007-09-21

Importance Nonsyndromic bicuspid aortic valve (nsBAV) is the most common congenital heart malformation. BAV has a heritable component, yet only few causative genes have been identified; understanding genetics key point in developing personalized medicine. Objective To identify new gene for nsBAV. Design, Setting, and Participants This was comprehensive, multicenter, genetic association study based on candidate prioritization familial cohort followed by rare studies replication cohorts....

10.1001/jamacardio.2023.1469 article EN JAMA Cardiology 2023-07-05

A higher than normal incidence of thromboembolic events has been observed in adult patients with β‐thalassaemia major (TM) and certain haemostatic anomalies found these suggest the existence a chronic hypercoagulable state. Thalassaemic red blood cells (RBC) were demonstrated to facilitate thrombin formation due altered asymmetry membrane phospholipids enhanced exposure phosphatidylserine. Since RBC exist thalassaemia from first months life, we studied markers hypercoagulability...

10.1046/j.1365-2141.1999.01758.x article EN British Journal of Haematology 1999-12-01

CD4-positive lymphocytes, the major T-cell population in human atheroma, mainly secrete Th-1-type proinflammatory cytokines, like interferon (IFN)gamma, tumor necrosis factor (TNF)alpha, and interleukin (IL)-2, thus promoting atherogenesis. Recent data suggest that nuclear transcription factors liver X receptor-alpha receptor-beta (LXRalpha LXRbeta) limit plaque formation animal models by modulating macrophage function. Still, role of LXRs lymphocytes is currently unexplored.Human express...

10.1161/01.atv.0000210278.67076.8f article EN Arteriosclerosis Thrombosis and Vascular Biology 2006-02-17

Increased levels of C-peptide, a cleavage product proinsulin, circulate in patients with insulin resistance and early type 2 diabetes mellitus. Recent data suggest potential causal role C-peptide atherogenesis by promoting monocyte T-lymphocyte recruitment into the vessel wall. The present study examined effect on vascular smooth muscle cells (VSMCs) proliferation evaluated intracellular signaling pathways involved. In arteriosclerotic lesions diabetic subjects, colocalized VSMCs media....

10.1161/01.res.0000251231.16993.88 article EN Circulation Research 2006-10-27
Coming Soon ...